Thyrocare Technologies Ltd. announced its quarterly results on July 31, 2020. Consolidated net revenue in Q1FY21 stood at Rs56.27cr, which declined by 48.72% yoy from Rs109.73cr in Q1FY20.
EBITDA stood at Rs8.46cr in Q1FY21 that decreased by 81.45% yoy. For Q1FY20, it had posted EBITDA of Rs45.61cr. EBITDA margin as of Q1FY21 was at 15.03% that declined by 26.54% yoy compared to the same quarter, the previous year.
The consolidated net profit in Q1FY21 came in at Rs0.23cr that declined by 99.16% yoy, as compared to Q1FY20, when it had reported Rs27.47cr. The net profit margin in Q1FY21 came in at 0.41% that declined by 24.62% yoy. The net profit margin for Q1FY20 was at 25.03%.
On Friday, the shares of company closed at Rs701.95 on BSE.
|
Particulars |
Q1FY21 (Rs in cr) |
Q1FY20 (Rs in cr) |
% VAR |
|
Net Revenue |
56.27 |
109.73 |
-48.72 |
|
Operating Profit |
8.46 |
45.61 |
-81.45 |
|
Net Profit |
0.23 |
27.47 |
-99.16 |
|
EBITDAM% |
15.03 |
41.57 |
-26.54 |
|
PATM% |
0.41 |
25.03 |
-24.62 |
Related Tags:
